Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies

The purpose of the research study is to test an angiotensin converting enzyme (ACE) inhibitor, lisinopril, and an antioxidant, coenzyme Q10 (CoQ10), to ameliorate the decline in cardiac muscle function that occurs in muscular dystrophies. To learn more about the study eligibility and participating sites please visit: